Search

Search Constraints

You searched for: Author/Creator Talbot, Alexis

Search Results

1. Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. (3rd February 2020)

2. CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment. Issue 3 (21st June 2022)

3. Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature. (15th December 2019)

5. Inflammatory Waldenström's macroglobulinaemia: A French monocentric retrospective study of 67 patients. (8th April 2022)

6. Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series. Issue 11 (23rd August 2019)

7. Multiple myeloma occurring in a case of Niemann‐Pick disease Type B: A pathophysiological link?. (10th February 2022)

9. Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort. (24th May 2022)